Compare Twist Bioscience Corp (TWST) vs United Microelectronics Corp (UMC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Twist Bioscience Corp vs United Microelectronics Corp — how do they compare? Twist Bioscience Corp trades at $154.45 (market cap $10.08B), while United Microelectronics Corp trades at $23 (market cap $58.02B). The key difference: United Microelectronics Corp is far larger — about 5.8× Twist Bioscience Corp's market cap, and United Microelectronics Corp pays a 1.76% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Twist Bioscience Corp for 27 Days and United Microelectronics Corp for 42 Days on average.
| TWST | UMC | |
|---|---|---|
Market Cap | $10.08B | $58.02B |
Volume | 4,229,037 | 11,897,809 |
Sector | Health | Technology |
52-Week High | $205.00 | $28.02 |
52-Week Low | $25.45 | $7.02 |
Typical Hold Time | 27 Days | 42 Days |
Enterprise Value | $10.01B | $55.10B |
Dividend Yield | — | 1.76% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TWST trades at $155.65, down 6.78% today, reflecting a bearish technical signal and recent earnings misses. Revenue growth is strong, rising to $376.57M in 2025, but profitability remains elusive with a net income margin of -31.66%. The company's partnership with Lilly TuneLab for AI-driven drug discovery has generated positive news flow, yet cash flow remains negative, and the stock trades at elevated valuation multiples like P/S of 22.01.
The outlook is mixed: strong analyst buy-side consensus (73% Buy) and strategic AI partnerships offer growth potential, but persistent losses, high cash burn, and bearish technicals pose significant risks. Investors face a trade-off between long-term innovation prospects and near-term financial instability.
United Microelectronics (UMC) trades at $23.31, up 0.52% with a bullish technical signal despite mixed moving averages. The company shows strong profitability with 32.75% net income margin and 21.03% ROE, though revenue growth has slowed from 2022 peaks. Recent earnings beats and positive 2026 projections suggest operational strength, while analyst consensus remains cautious with 53% hold ratings.
UMC presents a mixed outlook with strong fundamentals offset by valuation concerns. The stock's 250% annual gain creates near-term resistance, while projected 2026 earnings growth of 103% offers upside potential. Key risks include semiconductor cyclicality and AI spending volatility, requiring careful position sizing despite intrinsic value estimates near $29.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →About United Microelectronics Corp
Founded in 1980, United Microelectronics is the world's third-largest dedicated chip foundry, with 7% market share in 2021, according to Gartner, after TSMC and GlobalFoundries. UMC's headquarters are in Hsinchu, Taiwan, and it operates 12 fabs in Taiwan, Mainland China, Japan and Singapore, with additional sales offices in Europe, the U.S. and South Korea. UMC features a diverse customer base including Texas Instruments, MediaTek, Qualcomm, Broadcom, Xilinx and Realtek, supplying a wide range of products applied in communications, display, memory, automotive and more. UMC employs about 20,000 people.
Read more on UMC →
